News

Hormone treatment increases breast cancer risk, study shows

BMJ 2003; 327 doi: 10.1136/bmj.327.7411.359 (Published 14 August 2003)
Cite this as: BMJ 2003;327:359.1

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Susan Mayor
  1. London

    Long term use of combined hormone replacement therapy (HRT) doubles the risk of breast cancer, according to a major epidemiological study published last week that showed for the first time the higher risk with combined oestrogen and progestogen treatment.

    From 1996 to 2001 the million women study recruited 1 084 110 women in the United Kingdom aged 50-64 years. When they were invited to attend for routine mammography the women were asked to complete a questionnaire that included questions about their use of HRT. They were then …

    Access to the full text of this article requires a subscription or payment

    Subscribe

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    Rapid responses

    THIS WEEK'S POLL

    BMJ most popular